Pembrolizumab monotherapy in patients with primary refractory classical Hodgkin lymphoma: Subgroup analysis of the Phase 2 KEYNOTE-087 study Meeting Abstract
| Authors: | Zinzani, P. L.; Fanale, M. A.; Chen, R.; Armand, P.; Johnson, N.; Brice, P.; Radford, J.; Ribrag, V.; Molin, D.; Vassilakopoulos, T. P.; Tomita, A.; Tresckow, B.; Shipp, M. A.; Zhang, Y.; Balakumaran, A.; Moskowitz, C. H. |
| Abstract Title: | Pembrolizumab monotherapy in patients with primary refractory classical Hodgkin lymphoma: Subgroup analysis of the Phase 2 KEYNOTE-087 study |
| Meeting Title: | 14th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Jun 14-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-06-07 |
| Start Page: | 136 |
| End Page: | 137 |
| Language: | English |
| ACCESSION: | 123459850 |
| DOI: | 10.1002/hon.2437_125 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 126 -- Accession Number: 123459850 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
